Breast cancer detection efforts intensify in Dominican Republic

Health experts and the Federation of Central American and Caribbean Pharmaceutical Laboratories (Fedefarma) are calling for improved breast cancer detection and faster diagnostic processes in the Dominican Republic and Central America. In the Dominican Republic, approximately 60% of breast cancer cases are diagnosed at advanced stages, according to reports. Specialist Víctor Calderón emphasized the necessity of mammographies to identify small lesions that cannot be felt during physical exams, noting that the disease often progresses silently without pain.

Fedefarma and clinical oncologist Silvia Alfaro have urged for a reduction in the time elapsed between performing a mammography, interpreting the results, and beginning treatment. They highlighted that the value of screening is only realized when results lead promptly to necessary follow-up studies. Additionally, medical professionals warned about inflammatory breast cancer, an aggressive form that may present with skin changes—such as redness or temperature increases—rather than a traditional lump, making it easy to misdiagnose as an infection.

Risk factors discussed include age, genetic mutations, family history, and lifestyle factors like sedentary behavior and overweight. Experts recommend that patients remain vigilant for symptoms such as skin dimpling, nipple discharge, or changes in breast shape, and that they provide medical staff with detailed family histories.